NO20005498L - Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstörrelse - Google Patents

Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstörrelse

Info

Publication number
NO20005498L
NO20005498L NO20005498A NO20005498A NO20005498L NO 20005498 L NO20005498 L NO 20005498L NO 20005498 A NO20005498 A NO 20005498A NO 20005498 A NO20005498 A NO 20005498A NO 20005498 L NO20005498 L NO 20005498L
Authority
NO
Norway
Prior art keywords
naphth
piperazine
sulfonyl
pyridyl
benzoyl
Prior art date
Application number
NO20005498A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005498D0 (no
Inventor
Marianne Ashford
Roger James
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20005498D0 publication Critical patent/NO20005498D0/no
Publication of NO20005498L publication Critical patent/NO20005498L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20005498A 1998-05-02 2000-11-01 Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstörrelse NO20005498L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809350.3A GB9809350D0 (en) 1998-05-02 1998-05-02 Novel salt
PCT/GB1999/001316 WO1999057112A1 (en) 1998-05-02 1999-04-27 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine

Publications (2)

Publication Number Publication Date
NO20005498D0 NO20005498D0 (no) 2000-11-01
NO20005498L true NO20005498L (no) 2000-11-01

Family

ID=10831311

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005498A NO20005498L (no) 1998-05-02 2000-11-01 Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstörrelse

Country Status (16)

Country Link
EP (1) EP1084118A1 (sk)
JP (1) JP2002513789A (sk)
KR (1) KR20010043216A (sk)
CN (1) CN1308629A (sk)
AU (1) AU3719699A (sk)
BR (1) BR9910176A (sk)
CA (1) CA2331041A1 (sk)
EE (1) EE200000638A (sk)
GB (1) GB9809350D0 (sk)
HU (1) HUP0102394A3 (sk)
IL (1) IL139405A0 (sk)
NO (1) NO20005498L (sk)
PL (1) PL343705A1 (sk)
SK (1) SK16522000A3 (sk)
WO (1) WO1999057112A1 (sk)
ZA (1) ZA200006036B (sk)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2255733T3 (es) * 1997-09-30 2006-07-01 Daiichi Pharmaceutical Co., Ltd. Derivados sulfonilo.
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
US7365205B2 (en) 2001-06-20 2008-04-29 Daiichi Sankyo Company, Limited Diamine derivatives
HUE025683T2 (hu) 2002-12-03 2016-04-28 Pharmacyclics Llc VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA56197C2 (uk) * 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
WO1998054164A1 (en) * 1997-05-30 1998-12-03 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
ES2255733T3 (es) * 1997-09-30 2006-07-01 Daiichi Pharmaceutical Co., Ltd. Derivados sulfonilo.

Also Published As

Publication number Publication date
ZA200006036B (en) 2002-01-25
NO20005498D0 (no) 2000-11-01
CA2331041A1 (en) 1999-11-11
HUP0102394A2 (hu) 2001-12-28
GB9809350D0 (en) 1998-07-01
BR9910176A (pt) 2001-01-09
EE200000638A (et) 2002-04-15
KR20010043216A (ko) 2001-05-25
HUP0102394A3 (en) 2003-01-28
WO1999057112A1 (en) 1999-11-11
PL343705A1 (en) 2001-08-27
IL139405A0 (en) 2001-11-25
EP1084118A1 (en) 2001-03-21
JP2002513789A (ja) 2002-05-14
SK16522000A3 (sk) 2001-05-10
AU3719699A (en) 1999-11-23
CN1308629A (zh) 2001-08-15

Similar Documents

Publication Publication Date Title
SE8207425L (sv) 2-(4-((4,4-dialkyl-2,6-piperidindion-1-yl)butyl)-1-piperazinyl)pyrimidiner
NO20015746L (no) Ny anvendelse av 1-[4-(5-cyanindol-3-yl)butyl]-4-(2- karbamoylbenzofuran-5-yl)-piperazin og dets fysiologisk akseptablesalter
NO924764D0 (no) 4-pyrimidinyl- og pyridinylderivater av indol-3-yl-alkylpiperazin
FI19991729A (fi) 1-((4-Kloorifenyyli)fenyylimetyyli)-4-((4-metyylifenyyli)sulfonyyli)piperatsiinin enantiomeerit
DE60125980D1 (de) P38kinase-inhibitoren vom piperidin/piperazin-typ
DE60142613D1 (de) Aryl substituierte pyridinen, pyrimidinen, pyrazinen und triazinen und deren verwendung
NO20000115D0 (no) Gastrokinetiske monocykliske benzamider av 3- eller 4- substituerte 4-(aminometyl)-piperidinderivater
ATE306487T1 (de) Purinhemmer von cyclinabhängiger kinase 2 und ikb-alpha
CH1175401H1 (de) Piperazin Derivate verwendbar als CCR5 Antagonisten
ME00901B (me) Mezilat trihidrat 5-(2-(4-(1 ,2-benzizotiazol-3-il)-1-piperazinil)-etil)-6-hlor0-1,3-dihidr0-2h-indol-2-ona
NO984380D0 (no) Nye piperazin og piperidin forbindelser
DE69731094D1 (de) MESYLATDIHYDRATSALZE von 5-(2-(4-(1,2-BENZISOTHIAZOL-3-yl)-1-PIPERAZINYL)-ETHYL)-6-CHLORO-1,3-DIHYDRO-2(1H)-INDOL-2-ON (=ZIPRASIDONE), DESSEN HERSTELLUNG UND VERWENDUNG ALS DOPAMIN-D2-ANTAGONIST
ES8402832A1 (es) Un procedimiento para la preparacion de compuestos dotados de propiedades psicotropicas.
MX9305027A (es) 4- 2-(4-(2-piridiniloxi)fenil)etoxi] quinazolina yanalogos de la misma.
ATE116316T1 (de) Antipsychotische 4-(1,2- benzisoazolyl)piperidinderivate.
NO20005498L (no) Form av 1-(6-klornaft-2-ytsulfonyl)-4-[4-(4- pyridyl)benzoyl]piperazin med redusert partikkelstörrelse
DE59905472D1 (de) Verwendung von 2-(n-phenylamino)pyrimidinen als fungizide sowie neue 2-(n-phenylamino)pyrimidine
NO20013832D0 (no) Piperidin- og piperazinderivater som hemmere ved Abeta-fibril- dannelsen
ATE203237T1 (de) Pseudopolymorphische formen des 2-(2-(4-(bis(4- fluorophenyl)methyl)-1- piperazinyl)ethoxy)essigsäure dihydrochlorids
FI971831A (fi) Heterosyklillä substituoituja propeenihappojohdannaisia NMDA-antagonisteina
DE60204791D1 (de) Synthese von 4-(piperidyl) (2-pyridyl)methanon-(e)-o-methyloxim und seinen salzen
NO20031698D0 (no) Krystallformer av 1-(6-klor-5-(trifluormetyl)-2- pyridinyl)piperazin-hydroklorid
AU2002359274A1 (en) Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts
AU2001225369A1 (en) Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
HU0401645D0 (en) Alpha crystal form of 4-(4-methyl-piperazine-1-yl-methyl)-n-[4-methyl-3-(4-pyridine-3-yl)-pyrimidine-2-yl-amino]-phenyl)-benzamide monomethanesulfonate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application